Dow Down 0.92% Nasdaq Down 0.83%

Arrowhead Research Corp. (ARWR)

-NasdaqGS
6.75 Oct 22, 4:00PM EDT
Prev Close:6.75
Open:N/A
Bid:6.67 x 200
Ask:6.86 x 2000
1y Target Est:17.75
Beta:3.09
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:N/A - N/A
52wk Range:5.47 - 27.63
Volume:1,000
Avg Vol (3m):4,687,070
Market Cap:357.13M
P/E (ttm):N/A
EPS (ttm):-1.15
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ARWR

Comparison

Symbol% ChgMkt Cap
ARWR 0.00%357.13M
APNTN/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2,040.75
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Sep-14) :-1.05
Quarterly EPS Est (Sep-14) :-0.24
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):-0.91

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Arrowhead Research Corporation, a biopharmaceutical company, develops targeted RNAi therapeutics in the United States. The company’s product candidate comprise ARC-520, an RNAi-based therapeutic that has completed a Phase 1 clinical trial for... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback